Home | Multiple Myeloma Hub

I'm interested in

A global online educational platform sharing the latest research and emerging treatment information in multiple myeloma

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology

Professional society

The European School of Haematology (ESH) is a not for profit institution for the dissemination of information and lifelong learning founded in 1985 to promote and facilitate access to state-of-the-art and cutting-edge knowledge in haematology and related disciplines at the European level. ESH Conferences present state-of-the-art science and insight into new developments in the fields of basic, clinical and therapeutic research in Haematology

Our supporters

Silver

Bronze

Contributor

Latest Medical Information

Recently updated Licenses

DARZALEX® (daratumumab) is indicated for the treatment of newly diagnosed myeloma patients who are ineligible…

Xgeva® is indicated for the prevention of skeletal-related events in patients with multiple myeloma and in…

DARZALEX® is indicated for use in combination with pomalidomide and dexamethasone for the treatment of…

VELCADE® as monotherapy or in combination with pegylated liposomal doxorubicin or dexamethasone is indicated…

Connect with us

MM Hub newsletter

Sign up for our monthly newsletter, bringing you highlights of our coverage direct to your inbox!

Our sister hubs

Professional society

Our supporters